|
Volumn 34, Issue 3, 2003, Pages 348-350
|
Does Prior Short-Course Nevirapine Reduce the Effectiveness of Subsequent Combination Treatment With Efavirenz? [4]
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
EFAVIRENZ;
NEVIRAPINE;
ADULT;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
MALE;
PERINATAL INFECTION;
PRIORITY JOURNAL;
PUERPERIUM;
SHORT COURSE THERAPY;
TREATMENT FAILURE;
UNITED STATES;
VERTICAL TRANSMISSION;
VIRUS LOAD;
VIRUS MUTANT;
ADULT;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CD4 LYMPHOCYTE COUNT;
DRUG INTERACTIONS;
DRUG THERAPY, COMBINATION;
FEMALE;
HIV INFECTIONS;
HIV-1;
HUMANS;
LONGITUDINAL STUDIES;
MALE;
MIDDLE AGED;
NEVIRAPINE;
OXAZINES;
REVERSE TRANSCRIPTASE INHIBITORS;
|
EID: 0242664906
PISSN: 15254135
EISSN: None
Source Type: Journal
DOI: 10.1097/00126334-200311010-00017 Document Type: Letter |
Times cited : (3)
|
References (4)
|